Peptone

About:

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

Website: https://peptone.io

Twitter/X: peptoneltd

Top Investors: Bessemer Venture Partners, F-Prime Capital, Founders Factory, Hoxton Ventures, Walden Catalyst

Description:

We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.

Total Funding Amount:

$42.4M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2018-01-01

Contact Email:

partnering(AT)peptone.io

Founders:

Kamil Tamiola, Matt Heberling

Number of Employees:

11-50

Last Funding Date:

2022-06-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai